Synopsys Inc. (SNPS) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q1 27	$3.67	$3.91	+6.5%	—	—	—
Q4 26	$3.16	$3.35	+6.0%	—	—	—
Q3 26	$3.56	$3.77	+5.9%	—	—	—
Q2 26	$2.78	$2.9	+4.3%	—	—	—
Q1 26	$3.75	$3.39	-9.6%	—	—	—
Q4 25	$3.4	$3.67	+7.9%	—	—	—
Q3 25	$2.79	$3.03	+8.6%	—	—	—
Q2 25	$3.3	$3.4	+3.0%	—	—	—
Q1 25	$3.29	$3.43	+4.3%	—	—	—
Q4 24	$2.95	$3	+1.7%	—	—	—
Q3 24	$3.41	$3.56	+4.4%	—	—	—
Q2 24	$3.04	$3.17	+4.3%	—	—	—
Q1 24	$2.74	$2.88	+5.1%	—	—	—
Q4 23	$2.46	$2.54	+3.3%	—	—	—
Q3 23	$2.5	$2.62	+4.8%	—	—	—
Q2 23	$1.85	$1.91	+3.2%	—	—	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY25	—	$8.13	—	—	$7.1B	—
FY24	—	$14.8	—	—	$6.1B	—
FY23	—	$8.08	—	—	$5.3B	—
FY22	—	$6.44	—	—	$4.6B

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	$2.4B	$2.7B	$3.1B	$3.4B	$3.7B	$4.2B	$4.6B	$5.3B	$6.1B	$7.1B
YoY change	+8.04%	+12.5%	+14.5%	+7.68%	+9.66%	+14.1%	+9.79%	+15.2%	+15.2%	+15.1%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	2.4B	2.7B	3.1B	3.4B	3.7B	4.2B	4.6B	5.3B	6.1B	7.1B
Cost of revenue	543M	654.2M	735.9M	752.9M	794.7M	861.8M	898M	1B	1.2B	1.6B
Gross profit	1.9B	2.1B	2.4B	2.6B	2.9B	3.3B	3.7B	4.3B	4.9B	5.4B
Gross margin	77.6%	76%	76.4%	77.6%	78.4%	79.5%	80.5%	80.6%	79.7%	77%
Research & development	856.7M	908.8M	1.1B	1.1B	1.3B	1.5B	1.6B	1.8B	2.1B	2.5B
Selling, general & administrative	668.3M	746.1M	885.5M	862.1M	916.5M	1B	956.3M	1.1B	1.4B	1.8B
Operating expenses	1.5B	1.7B	2B	2B	2.2B	2.5B	2.5B	3B	3.5B	4.3B
Operating income	327M	384.1M	373.2M	567.4M	656.2M	768.2M	1.2B	1.3B	1.4B	914.9M
Operating margin	13.5%	14.1%	12%	16.9%	17.8%	18.3%	25.1%	24.9%	22.1%	13%
Non-operating income, net	2.6M	-989K	657K	-17.1M	-16.5M	38.2M	-63.3M	-56.4M	40.8M	647.3M
Pretax income	329.5M	383.1M	363.5M	545.5M	638.2M	805.5M	1.1B	1.3B	1.5B	1.4B
Income tax	62.7M	246.5M	-69M	13.1M	-25.3M	49.2M	139.4M	90.2M	99.7M	56M
Net income	266.8M	136.6M	432.5M	532.4M	663.4M	756.4M	978.4M	1.2B	2.2B	1.3B
Net margin	11%	5.01%	13.9%	15.8%	18%	18%	21.2%	22.9%	36.5%	18.9%
EBITDA	549.8M	613.1M	597.7M	802.4M	883.8M	1B	1.3B	1.6B	1.8B	1.9B
EPS	1.76	0.91	2.9	3.55	4.4	4.96	6.44	8.08	14.8	8.13
Diluted EPS	1.73	0.88	2.82	3.45	4.27	4.81	6.29	7.92	14.5	8.04

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26
Revenue	1.6B	1.6B	1.5B	1.5B	1.6B	1.5B	1.6B	1.7B	2.3B	2.4B	2.3B	2.5B
Cost of revenue	332.3M	329.2M	300.4M	290.7M	375M	270M	318.3M	380.6M	654.7M	637.4M	629.9M	679.4M
Gross profit	1.3B	1.3B	1.2B	1.2B	1.3B	1.2B	1.3B	1.4B	1.6B	1.8B	1.6B	1.8B
Gross margin	79.2%	80%	79.4%	80.9%	77.1%	81.4%	80.2%	78.1%	71%	73.5%	72.3%	72.6%
Research & development	488.5M	552.1M	493.1M	508.9M	554.8M	553.2M	554M	625.3M	746.8M	715M	700.1M	719.7M
Selling, general & administrative	341.1M	401.8M	324.5M	361.9M	391.3M	376.3M	351.5M	540M	576M	579.1M	554.4M	562.9M
Operating expenses	829.6M	953.8M	817.7M	870.8M	946.1M	929.5M	905.5M	1.2B	1.3B	1.3B	1.3B	1.3B
Operating income	429.1M	359.6M	332.1M	360.2M	310.8M	251.8M	376.4M	165.3M	121.4M	321.3M	236.3M	359.7M
Operating margin	26.8%	21.8%	22.8%	23.6%	19%	17.3%	23.5%	9.5%	5.38%	13.3%	10.4%	14.5%
Non-operating income, net	-29M	93.7M	-6.9M	2M	-7.8M	-5.4M	24.2M	39.1M	569.2M	-97M	-96.6M	439M
Pretax income	409.7M	465.1M	341.5M	392M	322.9M	291.1M	396.2M	189.3M	516.5M	79.1M	19.3M	683.9M
Income tax	63.2M	18.9M	45.4M	-30.7M	62.1M	-6.3M	47.2M	-53M	68.1M	14.3M	2.4M	138.2M
Net income	346.5M	446.2M	289.1M	404.9M	1.1B	297.4M	345.1M	242.3M	448.5M	65.2M	16.9M	545.7M
Net margin	21.7%	27.1%	19.9%	26.5%	67%	20.4%	21.5%	13.9%	19.9%	2.71%	0.74%	22%
EBITDA	477.5M	470.9M	409.1M	459.7M	450.7M	349.7M	490.7M	450.3M	610.8M	816.6M	726.6M	846.1M
EPS	2.3	2.95	1.91	2.66	7.24	1.91	2.23	1.51	2.42	0.34	0.09	2.85
Diluted EPS	2.26	2.89	1.88	2.61	7.14	1.89	2.21	1.5	2.39	0.34	0.09	2.84

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Market cap	9B	13B	13.3B	20.3B	32.3B	50.9B	44.8B	71.4B	78.7B	74.4B	80B
Enterprise value	8.1B	12.1B	13.1B	19.8B	31.7B	50B	43.9B	70.5B	75.3B	85.7B	87.3B
Shares outstanding	152M	150.5M	149M	149.9M	151.1M	152.7M	153M	152.1M	153.1M	163.9M	163.9M

Valuation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
P/E	33.8	95.3	30.9	38.2	48.7	67.3	45.7	58.6	35.2	55.8	74
P/S	3.72	4.78	4.28	6.05	8.77	12.1	9.7	13.4	12.8	10.5	8.5
P/B	2.82	3.97	3.83	4.98	6.58	9.6	8.05	11.5	8.72	2.63	2.57
EV/EBITDA	14.7	19.8	21.9	24.6	35.9	48	32.7	43.8	42.2	45.1	42
EV/Sales	3.35	4.45	4.19	5.88	8.62	11.9	9.5	13.3	12.3	12.2	9.27
Earnings yield	2.96%	1.05%	3.24%	2.62%	2.05%	1.49%	2.19%	1.71%	2.84%	1.79%	1.35%
FCF yield	5.72%	4.29%	2.42%	2.94%	2.58%	2.75%	3.57%	2.12%	1.63%	1.81%	4.28%
PEG	—	—	—	—	—	—	—	—	—	—	0.83

Profitability

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Gross margin	77.6%	76%	76.4%	77.6%	78.4%	79.5%	80.5%	80.6%	79.7%	77%	72.6%
Operating margin	13.5%	14.1%	12%	16.9%	17.8%	18.3%	25.1%	24.9%	22.1%	13%	14.5%
Net margin	11%	5.01%	13.9%	15.8%	18%	18%	21.2%	22.9%	36.5%	18.9%	11.4%
ROE	8.35%	4.16%	12.4%	13%	13.5%	14.3%	17.6%	19.7%	24.8%	4.71%	3.66%
ROA	5.09%	2.53%	7.04%	8.31%	8.26%	8.64%	10.4%	11.8%	17.1%	2.76%	1.35%
ROIC	11.6%	5.76%	11.5%	15.8%	15.1%	16.4%	21.8%	23.4%	22.4%	2.21%	2.24%
Return on tangible assets	-81%	-26%	-50.2%	-107.3%	83.9%	72.6%	101.8%	38.5%	38.6%	-4.31%	-3.73%

Financial health

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Current ratio	1	1.04	0.73	0.99	1.19	1.16	1.09	1.15	2.44	1.62	1.34
Quick ratio	1	1	0.68	0.91	1.1	1.07	1.01	1.04	2.3	1.52	1.24
Debt / equity	0.06	0.04	0.13	0.03	0.14	0.13	0.12	0.11	0.08	0.5	0.35
Debt / assets	0.04	0.03	0.08	0.02	0.08	0.08	0.07	0.07	0.05	0.3	0.23
Net debt / EBITDA	-1.66	-1.48	-0.42	-0.74	-0.65	-0.88	-0.68	-0.56	-1.89	5.96	2.41
Interest coverage	88.4	53.5	24.3	47.8	125.2	240.4	650.9	1.1K	44.1	4.12	3.08
Effective tax rate	19%	64.4%	0%	2.41%	0%	6.1%	12.6%	6.91%	6.59%	4.02%	17.2%

Per share

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Revenue per share	15.9	18.1	20.9	22.4	24.4	27.5	30.2	35	40	43	49.6
EPS (basic)	1.76	0.91	2.9	3.55	4.4	4.96	6.44	8.08	14.8	8.13	8.13
EPS (diluted)	1.73	0.88	2.82	3.45	4.27	4.81	6.29	7.92	14.5	8.04	5.64
Book value per share	21	21.8	23.4	27.3	32.5	34.7	36.3	40.6	58.9	172.8	162.6
FCF per share	3.39	3.71	2.16	3.99	5.51	9.15	10.5	9.93	8.38	8.23	14.3
Cash per share	7.35	6.97	4.85	4.86	8.18	10.4	10.2	10.4	26.4	18.1	18.8
Capex per share	0.44	0.47	0.65	1.32	1.02	0.61	0.89	1.25	0.8	0	0

Capital allocation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Capex / revenue	2.76%	2.58%	3.12%	5.9%	4.2%	2.23%	2.96%	3.57%	2.01%	0%	0%
Capex / operating cash flow	11.7%	14%	25.3%	23.1%	17.8%	6.46%	7.32%	11.7%	4.86%	0%	0%
Payout ratio	—	—	—	—	—	—	—	—	—	—	0%

Period	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26
Revenue	$1.6B	$1.6B	$1.5B	$1.5B	$1.6B	$1.5B	$1.6B	$1.7B	$2.3B	$2.4B	$2.3B	$2.5B
YoY change	+24.5%	+21.1%	+15.2%	+12.7%	+2.3%	-11.8%	+10.3%	+14%	+37.8%	+65.5%	+41.9%	+42.4%

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Cash & short-term investments	1.1B	1B	723.1M	728.6M	1.2B	1.6B	1.6B	1.6B	4.1B	3B
Receivables	438.9M	451.1M	554.2M	524.8M	758.3M	563.6M	779.4M	835.3M	941.3M	1.5B
Inventory	—	61.9M	122.4M	141.5M	192.3M	229M	211.9M	325.6M	361.8M	365.2M
Total current assets	1.7B	1.7B	1.5B	1.7B	2.5B	2.8B	3B	3.4B	6.5B	6B
Property, plant & equipment	188.8M	197.1M	240.8M	360.8M	819.9M	830.7M	906.7M	974.5M	1B	1.3B
Goodwill & intangibles	5.6B	5.9B	7B	6.9B	7.2B	7.7B	8.5B	7.2B	7.3B	79.2B
Total assets	5.2B	5.4B	6.1B	6.4B	8B	8.8B	9.4B	10.3B	13.1B	48.2B
Accounts payable	13.7M	20M	85M	19.8M	30M	27.4M	37.6M	154.6M	207.3M	164.8M
Short-term debt	205M	9.9M	343.8M	17.6M	100.3M	154.7M	54.3M	79.8M	94.8M	150.3M
Total current liabilities	1.7B	1.6B	2.1B	1.8B	2.1B	2.4B	2.8B	3B	2.7B	3.7B
Long-term debt	—	134.1M	125.5M	120.1M	563.2M	512.1M	602.1M	597.8M	589.7M	14.1B
Total liabilities	2B	2.1B	2.7B	2.3B	3.1B	3.5B	3.9B	4.1B	4.1B	19.9B
Shareholders' equity	3.2B	3.3B	3.5B	4.1B	4.9B	5.3B	5.6B	6.2B	9B	28.3B
Total debt	205M	144M	469.3M	137.7M	663.5M	666.8M	656.4M	677.6M	684.5M	14.3B
Net debt	-771.6M	-904.4M	-253.8M	-590.9M	-572.2M	-766.1M	-761.2M	-756.4M	-3.2B	11.4B

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26
Cash & short-term investments	1.6B	1.3B	1.7B	2B	4.1B	3.8B	14.3B	2.6B	3B	2.2B	2.5B	3.6B
Receivables	835.3M	1.1B	834.9M	805.2M	941.3M	892.6M	1B	1.4B	1.5B	1.6B	1.3B	1.3B
Inventory	325.6M	382.7M	377.9M	386M	361.8M	415.2M	395.3M	382.1M	365.2M	393.2M	441.8M	479.1M
Total current assets	3.4B	3.4B	4.7B	5.1B	6.5B	6.3B	16.9B	5.6B	6B	5.4B	5.4B	6.6B
Property, plant & equipment	974.5M	1.1B	1.1B	1.1B	1B	1.1B	1.2B	1.4B	1.3B	1.4B	1.4B	1.4B
Goodwill & intangibles	7.2B	9B	7.4B	7.4B	7.3B	7.2B	7.3B	80.1B	79.2B	78.3B	77.5B	76.6B
Total assets	10.3B	10.6B	11B	11.6B	13.1B	13B	23.8B	48.2B	48.2B	47.2B	46.9B	47.7B
Accounts payable	154.6M	76.8M	92.3M	78.5M	207.3M	101.5M	84.7M	132.9M	164.8M	113.3M	179.3M	196.8M
Short-term debt	79.8M	89.2M	84.5M	89.9M	94.8M	99.3M	127.1M	149.6M	150.3M	155.2M	157.6M	1.2B
Total current liabilities	3B	2.6B	2.5B	2.5B	2.7B	2.4B	2.4B	3.4B	3.7B	3.9B	3.8B	5B
Long-term debt	597.8M	580.8M	560.2M	584M	589.7M	565.7M	10.6B	15B	14.1B	10.7B	10.7B	9.7B
Total liabilities	4.1B	3.9B	3.8B	3.9B	4.1B	3.7B	13.8B	20.6B	19.9B	16.7B	16.4B	16.6B
Shareholders' equity	6.2B	6.7B	7.2B	7.7B	9B	9.3B	9.9B	27.6B	28.3B	30.5B	30.5B	31.2B
Total debt	677.6M	670M	644.7M	673.9M	684.5M	665M	10.7B	15.1B	14.3B	10.9B	10.8B	10.8B
Net debt	-756.4M	-449M	-858.2M	-1.2B	-3.2B	-3B	-3.4B	12.6B	11.4B	8.7B	8.4B	7.2B

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Net income	266.8M	136.6M	432.5M	532.4M	663.4M	756.4M	978.4M	1.2B	2.2B	1.3B
Depreciation & amortization	207M	189.4M	209.2M	201.7M	210M	203.7M	228.4M	247.1M	295.1M	660.4M
Stock-based compensation	97.6M	108.3M	140M	155M	248.6M	345.3M	459M	563.3M	692.3M	893.3M
Change in working capital	14.9M	-55M	-185.9M	-6.2M	-290.9M	107.2M	64.7M	-391.4M	-484.7M	-550M
Operating cash flow	572.3M	502.3M	384.7M	857.9M	868M	1.5B	1.9B	1.6B	2.5B	1.5B
Capital expenditure	-66.9M	-70.3M	-97.3M	-198.1M	-154.7M	-93.8M	-136.6M	-189.6M	-123.2M	0
Investing cash flow	-138.5M	-186.1M	-740.6M	-231.6M	-356.4M	-547.1M	-570.1M	-479.9M	1.2B	-15.8B
Dividends paid	—	—	—	—	—	—	—	—	—	—
Share repurchases	-400M	-380M	-400M	-329.2M	-242.1M	-753.1M	-1.1B	-1.2B	0	0
Financing cash flow	-306.9M	-373.1M	5.1M	-369M	135.9M	-748.7M	-1.1B	-1.2B	-181.3M	13.4B
Net change in cash	126.8M	-56.8M	-350.7M	257.3M	647.5M	155.3M	180M	-57.5M	3.6B	-911.7M
Free cash flow	515.6M	558.9M	322.5M	598.1M	832.6M	1.4B	1.6B	1.5B	1.3B	1.3B

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26
Net income	346.5M	446.2M	289.1M	404.9M	1.1B	297.4M	345.1M	242.3M	448.5M	64.7M	16.9M	545.7M
Depreciation & amortization	67.1M	62.9M	61M	56.3M	114.9M	47.9M	48.9M	114.5M	449.1M	450.7M	456.5M	454.8M
Stock-based compensation	141.3M	180.7M	177.8M	181.5M	152.3M	186.5M	201.7M	267.7M	237.4M	258.7M	222.3M	231.6M
Change in working capital	-249.2M	-306.9M	-62.9M	-140M	25.1M	-101.5M	-171.3M	-455.7M	178.5M	10.9M	50.5M	-205.6M
Operating cash flow	310.9M	324.8M	442.7M	450.1M	1.3B	339.8M	275.8M	671M	639.7M	856.8M	628.9M	812.8M
Capital expenditure	-53.1M	-40.4M	-38.4M	-40M	-4.4M	-40.7M	18.7M	—	—	—	—	—
Investing cash flow	-300.5M	-54.4M	-111.8M	-53.8M	1.4B	-22M	76M	-16.5B	599M	-1.2M	1.3M	509.7M
Dividends paid	—	—	—	—	—	—	—	—	—	—	—	—
Share repurchases	-300M	0	0	0	0	—	—	—	—	—	—	-37.5M
Financing cash flow	-254.3M	-187.2M	32.6M	-56.8M	30.1M	-141.8M	62M	4.2B	-835.9M	-1.6B	-18.5M	-37.8M
Net change in cash	-243.9M	83.3M	363.5M	339.5M	2.8B	176M	413.7M	-11.6B	402.9M	-727.5M	611.8M	1.3B
Free cash flow	273M	-128.2M	438.2M	415.4M	558.4M	-108.2M	219.8M	632.4M	605.2M	821.5M	574.7M	746.3M

Synopsys Inc. Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement